Back

Normative Reference Values for the FACE-Q Skin Cancer Module: Patient Preoperative Scores and Comparison With Healthy Partners

Ottenhof, M. J.

2026-02-16 surgery
10.64898/2026.02.12.26345805 medRxiv
Show abstract

BackgroundThe FACE-Q Skin Cancer Module is a condition-specific patient-reported outcome measure for facial skin cancer. While its psychometric properties have been established, normative reference values that enable score interpretation in clinical practice and research are lacking. ObjectiveTo establish normative reference values for the FACE-Q Skin Cancer Module using preoperative patient data and to validate these values by comparison with a demographically matched cohort of healthy partners. MethodsTwo cohorts were analyzed: 287 patients with facial skin cancer (preoperative scores) and 82 healthy partners of skin cancer patients (same-age population without facial skin cancer). Both cohorts completed the Appearance (9 items) and Psychosocial Distress (8 items) scales. Patients additionally completed the Cancer Worry scale (10 items) and Sun Protection scale (5 items). Scores were transformed to a 0-100 scale. Normative values were expressed as percentiles overall and stratified by sex and age group. Group comparisons used independent t-tests, Mann-Whitney U tests, and Cohens d. Internal consistency was assessed with Cronbachs alpha. ResultsPatient and partner cohorts were well matched for age (68.6{+/-}11.9 vs 68.4{+/-}13.0, p=0.902) and sex (46.7% vs 41.5% female, p=0.476). Surprisingly, preoperative facial appearance scores were virtually identical between patients and partners (55.6{+/-}14.0 vs 56.6{+/-}13.6, p=0.590, d=-0.08), as were psychosocial distress scores (14.3{+/-}12.0 vs 14.4{+/-}13.3, p=0.942, d=-0.01). This equivalence held across age groups. A significant sex interaction was identified: female patients scored lower on appearance than female partners (54.3 vs 59.9, p=0.048, d=-0.40), whereas no difference existed among males (56.9 vs 53.1, p=0.168). Internal consistency was excellent in both cohorts (Cronbachs 0.82-0.93). Patients reported marginally higher sun protection behaviors than partners (38.0 vs 33.6, p=0.050). ConclusionsPreoperative FACE-Q Skin Cancer scores in patients are equivalent to those of demographically matched healthy individuals, confirming that these scores serve as valid normative references. The established percentile norms enable clinicians and researchers to interpret individual patient scores in context. The sex-specific difference in appearance scores warrants further investigation.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 3%
29.3%
2
Cancers
200 papers in training set
Top 0.3%
10.7%
3
Scientific Reports
3102 papers in training set
Top 12%
7.2%
4
eBioMedicine
130 papers in training set
Top 0.1%
5.1%
50% of probability mass above
5
Trials
25 papers in training set
Top 0.2%
5.1%
6
Experimental Dermatology
10 papers in training set
Top 0.1%
3.8%
7
Scientific Data
174 papers in training set
Top 0.4%
3.8%
8
Frontiers in Oncology
95 papers in training set
Top 1%
3.0%
9
Frontiers in Medicine
113 papers in training set
Top 2%
2.9%
10
BMJ Open
554 papers in training set
Top 7%
2.2%
11
JMIR Research Protocols
18 papers in training set
Top 0.5%
2.0%
12
Transfusion
18 papers in training set
Top 0.1%
1.8%
13
BMJ Paediatrics Open
21 papers in training set
Top 0.5%
1.4%
14
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.4%
1.3%
15
Biology Methods and Protocols
53 papers in training set
Top 1%
1.3%
16
BMC Neurology
12 papers in training set
Top 0.8%
0.8%
17
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
0.8%
18
JAMA Network Open
127 papers in training set
Top 5%
0.7%
19
PLOS Medicine
98 papers in training set
Top 5%
0.5%
20
Journal of Clinical Medicine
91 papers in training set
Top 8%
0.5%
21
Experimental Eye Research
30 papers in training set
Top 0.6%
0.5%
22
Journal of Translational Medicine
46 papers in training set
Top 4%
0.5%